PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1600.0
(-1.23%)
IDR 1600.0
(-1.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 109.18 Billion | 182.49 Billion | 435.33 Billion | 106.58 Billion | 272.53 Billion | 26.62 Billion |
| Net Income | 146.33 Billion | 149.37 Billion | 146.5 Billion | 162.07 Billion | 221.78 Billion | 200.65 Billion |
| Depreciation & Amortization | 63.89 Billion | 33.12 Billion | 60.73 Billion | 56.58 Billion | 51.3 Billion | 49.74 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -101.04 Billion | -182.49 Billion | 228.09 Billion | -112.07 Billion | -552.42 Million | -200.65 Billion |
| Investing Cash Flow | -90.89 Billion | -56.99 Billion | -13.76 Billion | -60.57 Billion | -125.23 Billion | -59.25 Billion |
| Investments in PPE | -97.91 Billion | -60.21 Billion | -86.99 Billion | -62.8 Billion | -58.95 Billion | -45.48 Billion |
| Acquisitions | 7.02 Billion | 3.22 Billion | 3.5 Billion | 2.23 Billion | 3.67 Billion | 4.22 Billion |
| Investment purchases | - | - | -3.5 Billion | - | -69.95 Billion | -17.98 Billion |
| Sales/Maturities of investments | - | - | 69.72 Billion | - | 66.27 Billion | - |
| Other Investing Activities | 7.02 Billion | 1.19 Billion | 3.5 Billion | 2.23 Billion | -66.27 Billion | 4.22 Billion |
| Financing Cash Flow | -136 Billion | -153.59 Billion | -103.44 Billion | -119.9 Billion | -113.38 Billion | -119.36 Billion |
| Debt repayment | -481.8 Million | -52.79 Billion | -23.12 Billion | -2.78 Billion | - | - |
| Dividends payments | -135.52 Billion | -129.92 Billion | -125.44 Billion | -119.84 Billion | -119.61 Billion | -119.4 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 2.72 Billion | 6.23 Billion | 43.88 Million |
| Other Financing Activities | -481.79 Million | 29.11 Billion | 45.11 Billion | 2.72 Billion | 6.23 Billion | 43.88 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 357.02 Billion | 583.29 Billion | 265.31 Billion | 339.04 Billion | 306.11 Billion | 450.88 Billion |
| Cash at end of period | 240.04 Billion | 357.02 Billion | 583.29 Billion | 265.31 Billion | 339.04 Billion | 306.11 Billion |
| Capital Expenditure | -97.91 Billion | -60.21 Billion | -86.99 Billion | -62.8 Billion | -58.95 Billion | -45.48 Billion |
| Effect of forex changes on cash | 733.29 Million | 372.45 Million | -140.73 Million | 161.48 Million | -994.94 Million | 7.22 Billion |
| Net cash flow / Change in cash | -116.97 Billion | -226.27 Billion | 317.98 Billion | -73.73 Billion | 32.93 Billion | -144.76 Billion |
| Free Cash Flow | 11.26 Billion | 122.28 Billion | 348.34 Billion | 43.77 Billion | 213.58 Billion | -18.85 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28.03 Billion | 51.86 Billion | 67.48 Billion | 46.51 Billion | 146.33 Billion | 3.5 Billion |
| Depreciation & Amortization | 16.44 Billion | 13.48 Billion | 17.47 Billion | 17.28 Billion | 63.89 Billion | 15.57 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 228.48 Billion | -69.26 Billion | 16.49 Billion | -80.71 Billion | -101.04 Billion | 112.93 Billion |
| Investing Cash Flow | -21.93 Billion | -16.61 Billion | -27.32 Billion | -36.19 Billion | -90.89 Billion | -20.33 Billion |
| Investments in PPE | -26.02 Billion | -18.54 Billion | -28.57 Billion | -38.65 Billion | -97.91 Billion | -21.6 Billion |
| Acquisitions | 4.09 Billion | 1.92 Billion | 1.25 Billion | 2.45 Billion | 7.02 Billion | 1.27 Billion |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4.09 Billion | 1.92 Billion | 1.25 Billion | 2.45 Billion | 7.02 Billion | 1.27 Billion |
| Financing Cash Flow | -72.92 Billion | -120.45 Million | -120.45 Million | -48.33 Billion | -136 Billion | -87.46 Billion |
| Debt repayment | -361.35 Million | -120.45 Million | -120.45 Million | -173.22 Million | -481.8 Million | -103.89 Million |
| Dividends payments | -72.8 Billion | - | - | -48.16 Billion | -135.52 Billion | -87.36 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -72.92 Billion | -120.45 Million | - | -173.22 Million | -481.79 Million | -103.89 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 276.06 Billion | 296.52 Billion | 240.04 Billion | 340.97 Billion | 357.02 Billion | 316.72 Billion |
| Cash at end of period | 437.94 Billion | 276.06 Billion | 296.52 Billion | 240.04 Billion | 240.04 Billion | 340.97 Billion |
| Capital Expenditure | -26.02 Billion | -18.54 Billion | -28.57 Billion | -38.65 Billion | -97.91 Billion | -21.6 Billion |
| Effect of forex changes on cash | 222.69 Million | 188 Million | -58.91 Million | 515.13 Million | 733.29 Million | 26.6 Million |
| Net cash flow / Change in cash | 161.88 Billion | -20.46 Billion | 56.48 Billion | -100.92 Billion | -116.97 Billion | 24.24 Billion |
| Free Cash Flow | 230.48 Billion | -22.45 Billion | 55.4 Billion | -55.56 Billion | 11.26 Billion | 110.4 Billion |
SHREESHAY
RJDG
1980
FQT
603016
NETD